Sanofi India Limited (BOM:500674)
India · Delayed Price · Currency is INR 3,810.05
-16.95 (-0.44%)
At close: Mar 5, 2026
Sanofi India Market Cap
Sanofi India has a market cap or net worth of 87.75 billion as of March 5, 2026. Its market cap has decreased by -29.02% in one year.
Market Cap
87.75B
Enterprise Value
85.18B
Revenue
19.33B
Ranking
n/a
PE Ratio
24.63
Stock Price
3,810.05
Market Cap Chart
Since March 19, 2001, Sanofi India's market cap has increased from 11.29B to 87.75B, an increase of 677.56%. That is a compound annual growth rate of 8.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 88.14B | -6.47% |
| Dec 31, 2025 | 94.23B | -33.15% |
| Dec 31, 2024 | 140.97B | -24.12% |
| Dec 29, 2023 | 185.79B | 37.91% |
| Dec 30, 2022 | 134.72B | -25.89% |
| Dec 31, 2021 | 181.78B | -5.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 329.44B |
| AstraZeneca Pharma India | 217.49B |
| Granules India | 137.16B |
| Jubilant Pharmova | 131.98B |
| Rubicon Research | 125.77B |
| Caplin Point Laboratories | 125.45B |
| CORONA Remedies | 96.63B |
| Viyash Scientific | 87.86B |